QUOTED. Feb. 23, 2018. Anthony Arnold.
Executive SummaryAnthony Arnold, CEO of device-maker SetPoint, says the drug industry is underestimating what patients really want when it comes to treating rheumatoid arthritis (RA). Check out what he said here.
"Pharma companies may underestimate how strong the patient demand for [an] alternative to biologics is. Patients are looking for something different and don’t want to be on drugs for the rest of their life." –Anthony Arnold, CEO, SetPoint
Click here for a free trial of Medtech Insight